Absci Corporation’s ABSI share price has surged by 5.86%, which has investors questioning if this is right time to sell.

Absci gained on animal testing phaseout news, but the change has limited near-term impact on its investment case. Read why ...

In this article, we are going to take a look at where Absci Corporation (NASDAQ:ABSI) stands against the other best biotech penny stocks to invest in now. Goldman Sachs has spotlighted an often ...

Absci Corporation stock has dropped since January, driven by weak earnings and broader biotech sector pressures. Despite weak financials, Absci's internal pipeline, including ABS-101 and ABS-201 ...

VANCOUVER, Wash. and NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report ...

Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates ...

KeyBanc raised the firm’s price target on Absci (ABSI) to $9 from $5 and keeps an Overweight rating on the shares. Into Q1 earnings, the firm believes the focus for the HCIT sector will be on ...

7 analysts have expressed a variety of opinions on Absci (NASDAQ:ABSI) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table encapsulates their ...

In a report released today, Scott Schoenhaus from KeyBanc maintained a Buy rating on AbSci (ABSI – Research Report), with a price target of ...

Short interest in Absci Corp (NASDAQ:ABSI) increased during the last reporting period, rising from 18.83M to 20.57M. This put 22.75% of the company's publicly available shares short. Short ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech ...